The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Non-Invasive Drug Delivery Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2028
Synopsis
The Non-Invasive Drug Delivery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Non-Invasive Drug Delivery market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Non-Invasive Drug Delivery global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Artificial Pancreas segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Non-Invasive Drug Delivery include Adherium Limited, Capsule Technologies, Inc., Crossject S.A., Diabeloop SA, and HNS International, Inc., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Non-Invasive Drug Delivery market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Artificial Pancreas
Needle Free Injector
Digital Respiratory Devices
Other
Market segment by Application can be divided into
Hospital
Clinic
Other
The key market players for global Non-Invasive Drug Delivery market are listed below:
Adherium Limited
Capsule Technologies, Inc.
Crossject S.A.
Diabeloop SA
HNS International, Inc.
Inovio Pharmaceuticals, Inc.
Medtronic Plc.
Novartis AG
PenJet Corporation
PharmaJet
Portal Instruments
ResMed
Sensiron AG
Tandem Diabetes Care, Inc.
Teva Pharmaceuticals Industries Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Non-Invasive Drug Delivery product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Non-Invasive Drug Delivery, with price, sales, revenue and global market share of Non-Invasive Drug Delivery from 2019 to 2022.
Chapter 3, the Non-Invasive Drug Delivery competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Non-Invasive Drug Delivery breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Non-Invasive Drug Delivery market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Non-Invasive Drug Delivery.
Chapter 13, 14, and 15, to describe Non-Invasive Drug Delivery sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
The Non-Invasive Drug Delivery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Non-Invasive Drug Delivery market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Non-Invasive Drug Delivery global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Artificial Pancreas segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Non-Invasive Drug Delivery include Adherium Limited, Capsule Technologies, Inc., Crossject S.A., Diabeloop SA, and HNS International, Inc., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Non-Invasive Drug Delivery market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Artificial Pancreas
Needle Free Injector
Digital Respiratory Devices
Other
Market segment by Application can be divided into
Hospital
Clinic
Other
The key market players for global Non-Invasive Drug Delivery market are listed below:
Adherium Limited
Capsule Technologies, Inc.
Crossject S.A.
Diabeloop SA
HNS International, Inc.
Inovio Pharmaceuticals, Inc.
Medtronic Plc.
Novartis AG
PenJet Corporation
PharmaJet
Portal Instruments
ResMed
Sensiron AG
Tandem Diabetes Care, Inc.
Teva Pharmaceuticals Industries Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Non-Invasive Drug Delivery product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Non-Invasive Drug Delivery, with price, sales, revenue and global market share of Non-Invasive Drug Delivery from 2019 to 2022.
Chapter 3, the Non-Invasive Drug Delivery competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Non-Invasive Drug Delivery breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Non-Invasive Drug Delivery market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Non-Invasive Drug Delivery.
Chapter 13, 14, and 15, to describe Non-Invasive Drug Delivery sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Non-Invasive Drug Delivery Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Non-Invasive Drug Delivery Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Artificial Pancreas
1.2.3 Needle Free Injector
1.2.4 Digital Respiratory Devices
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Non-Invasive Drug Delivery Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Non-Invasive Drug Delivery Market Size & Forecast
1.4.1 Global Non-Invasive Drug Delivery Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Non-Invasive Drug Delivery Sales in Volume (2017-2028)
1.4.3 Global Non-Invasive Drug Delivery Price (2017-2028)
1.5 Global Non-Invasive Drug Delivery Production Capacity Analysis
1.5.1 Global Non-Invasive Drug Delivery Total Production Capacity (2017-2028)
1.5.2 Global Non-Invasive Drug Delivery Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Non-Invasive Drug Delivery Market Drivers
1.6.2 Non-Invasive Drug Delivery Market Restraints
1.6.3 Non-Invasive Drug Delivery Trends Analysis
2 Manufacturers Profiles
2.1 Adherium Limited
2.1.1 Adherium Limited Details
2.1.2 Adherium Limited Major Business
2.1.3 Adherium Limited Non-Invasive Drug Delivery Product and Services
2.1.4 Adherium Limited Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Capsule Technologies, Inc.
2.2.1 Capsule Technologies, Inc. Details
2.2.2 Capsule Technologies, Inc. Major Business
2.2.3 Capsule Technologies, Inc. Non-Invasive Drug Delivery Product and Services
2.2.4 Capsule Technologies, Inc. Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Crossject S.A.
2.3.1 Crossject S.A. Details
2.3.2 Crossject S.A. Major Business
2.3.3 Crossject S.A. Non-Invasive Drug Delivery Product and Services
2.3.4 Crossject S.A. Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Diabeloop SA
2.4.1 Diabeloop SA Details
2.4.2 Diabeloop SA Major Business
2.4.3 Diabeloop SA Non-Invasive Drug Delivery Product and Services
2.4.4 Diabeloop SA Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 HNS International, Inc.
2.5.1 HNS International, Inc. Details
2.5.2 HNS International, Inc. Major Business
2.5.3 HNS International, Inc. Non-Invasive Drug Delivery Product and Services
2.5.4 HNS International, Inc. Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Inovio Pharmaceuticals, Inc.
2.6.1 Inovio Pharmaceuticals, Inc. Details
2.6.2 Inovio Pharmaceuticals, Inc. Major Business
2.6.3 Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Product and Services
2.6.4 Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Medtronic Plc.
2.7.1 Medtronic Plc. Details
2.7.2 Medtronic Plc. Major Business
2.7.3 Medtronic Plc. Non-Invasive Drug Delivery Product and Services
2.7.4 Medtronic Plc. Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Novartis AG
2.8.1 Novartis AG Details
2.8.2 Novartis AG Major Business
2.8.3 Novartis AG Non-Invasive Drug Delivery Product and Services
2.8.4 Novartis AG Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 PenJet Corporation
2.9.1 PenJet Corporation Details
2.9.2 PenJet Corporation Major Business
2.9.3 PenJet Corporation Non-Invasive Drug Delivery Product and Services
2.9.4 PenJet Corporation Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 PharmaJet
2.10.1 PharmaJet Details
2.10.2 PharmaJet Major Business
2.10.3 PharmaJet Non-Invasive Drug Delivery Product and Services
2.10.4 PharmaJet Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Portal Instruments
2.11.1 Portal Instruments Details
2.11.2 Portal Instruments Major Business
2.11.3 Portal Instruments Non-Invasive Drug Delivery Product and Services
2.11.4 Portal Instruments Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 ResMed
2.12.1 ResMed Details
2.12.2 ResMed Major Business
2.12.3 ResMed Non-Invasive Drug Delivery Product and Services
2.12.4 ResMed Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Sensiron AG
2.13.1 Sensiron AG Details
2.13.2 Sensiron AG Major Business
2.13.3 Sensiron AG Non-Invasive Drug Delivery Product and Services
2.13.4 Sensiron AG Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Tandem Diabetes Care, Inc.
2.14.1 Tandem Diabetes Care, Inc. Details
2.14.2 Tandem Diabetes Care, Inc. Major Business
2.14.3 Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Product and Services
2.14.4 Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Teva Pharmaceuticals Industries Ltd.
2.15.1 Teva Pharmaceuticals Industries Ltd. Details
2.15.2 Teva Pharmaceuticals Industries Ltd. Major Business
2.15.3 Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Product and Services
2.15.4 Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Non-Invasive Drug Delivery Breakdown Data by Manufacturer
3.1 Global Non-Invasive Drug Delivery Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Non-Invasive Drug Delivery Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Non-Invasive Drug Delivery
3.4 Market Concentration Rate
3.4.1 Top 3 Non-Invasive Drug Delivery Manufacturer Market Share in 2021
3.4.2 Top 6 Non-Invasive Drug Delivery Manufacturer Market Share in 2021
3.5 Global Non-Invasive Drug Delivery Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Non-Invasive Drug Delivery Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Non-Invasive Drug Delivery Market Size by Region
4.1.1 Global Non-Invasive Drug Delivery Sales in Volume by Region (2017-2028)
4.1.2 Global Non-Invasive Drug Delivery Revenue by Region (2017-2028)
4.2 North America Non-Invasive Drug Delivery Revenue (2017-2028)
4.3 Europe Non-Invasive Drug Delivery Revenue (2017-2028)
4.4 Asia-Pacific Non-Invasive Drug Delivery Revenue (2017-2028)
4.5 South America Non-Invasive Drug Delivery Revenue (2017-2028)
4.6 Middle East and Africa Non-Invasive Drug Delivery Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Non-Invasive Drug Delivery Sales in Volume by Type (2017-2028)
5.2 Global Non-Invasive Drug Delivery Revenue by Type (2017-2028)
5.3 Global Non-Invasive Drug Delivery Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Non-Invasive Drug Delivery Sales in Volume by Application (2017-2028)
6.2 Global Non-Invasive Drug Delivery Revenue by Application (2017-2028)
6.3 Global Non-Invasive Drug Delivery Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Non-Invasive Drug Delivery Sales by Type (2017-2028)
7.2 North America Non-Invasive Drug Delivery Sales by Application (2017-2028)
7.3 North America Non-Invasive Drug Delivery Market Size by Country
7.3.1 North America Non-Invasive Drug Delivery Sales in Volume by Country (2017-2028)
7.3.2 North America Non-Invasive Drug Delivery Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Non-Invasive Drug Delivery Sales by Type (2017-2028)
8.2 Europe Non-Invasive Drug Delivery Sales by Application (2017-2028)
8.3 Europe Non-Invasive Drug Delivery Market Size by Country
8.3.1 Europe Non-Invasive Drug Delivery Sales in Volume by Country (2017-2028)
8.3.2 Europe Non-Invasive Drug Delivery Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Non-Invasive Drug Delivery Sales by Type (2017-2028)
9.2 Asia-Pacific Non-Invasive Drug Delivery Sales by Application (2017-2028)
9.3 Asia-Pacific Non-Invasive Drug Delivery Market Size by Region
9.3.1 Asia-Pacific Non-Invasive Drug Delivery Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Non-Invasive Drug Delivery Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Non-Invasive Drug Delivery Sales by Type (2017-2028)
10.2 South America Non-Invasive Drug Delivery Sales by Application (2017-2028)
10.3 South America Non-Invasive Drug Delivery Market Size by Country
10.3.1 South America Non-Invasive Drug Delivery Sales in Volume by Country (2017-2028)
10.3.2 South America Non-Invasive Drug Delivery Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Non-Invasive Drug Delivery Sales by Type (2017-2028)
11.2 Middle East & Africa Non-Invasive Drug Delivery Sales by Application (2017-2028)
11.3 Middle East & Africa Non-Invasive Drug Delivery Market Size by Country
11.3.1 Middle East & Africa Non-Invasive Drug Delivery Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Non-Invasive Drug Delivery Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Non-Invasive Drug Delivery and Key Manufacturers
12.2 Manufacturing Costs Percentage of Non-Invasive Drug Delivery
12.3 Non-Invasive Drug Delivery Production Process
12.4 Non-Invasive Drug Delivery Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Non-Invasive Drug Delivery Typical Distributors
13.3 Non-Invasive Drug Delivery Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of TablesList of Tables
Table 1. Global Non-Invasive Drug Delivery Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Non-Invasive Drug Delivery Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Adherium Limited Basic Information, Manufacturing Base and Competitors
Table 4. Adherium Limited Major Business
Table 5. Adherium Limited Non-Invasive Drug Delivery Product and Services
Table 6. Adherium Limited Non-Invasive Drug Delivery Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Capsule Technologies, Inc. Basic Information, Manufacturing Base and Competitors
Table 8. Capsule Technologies, Inc. Major Business
Table 9. Capsule Technologies, Inc. Non-Invasive Drug Delivery Product and Services
Table 10. Capsule Technologies, Inc. Non-Invasive Drug Delivery Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Crossject S.A. Basic Information, Manufacturing Base and Competitors
Table 12. Crossject S.A. Major Business
Table 13. Crossject S.A. Non-Invasive Drug Delivery Product and Services
Table 14. Crossject S.A. Non-Invasive Drug Delivery Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Diabeloop SA Basic Information, Manufacturing Base and Competitors
Table 16. Diabeloop SA Major Business
Table 17. Diabeloop SA Non-Invasive Drug Delivery Product and Services
Table 18. Diabeloop SA Non-Invasive Drug Delivery Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. HNS International, Inc. Basic Information, Manufacturing Base and Competitors
Table 20. HNS International, Inc. Major Business
Table 21. HNS International, Inc. Non-Invasive Drug Delivery Product and Services
Table 22. HNS International, Inc. Non-Invasive Drug Delivery Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Inovio Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 24. Inovio Pharmaceuticals, Inc. Major Business
Table 25. Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Product and Services
Table 26. Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Medtronic Plc. Basic Information, Manufacturing Base and Competitors
Table 28. Medtronic Plc. Major Business
Table 29. Medtronic Plc. Non-Invasive Drug Delivery Product and Services
Table 30. Medtronic Plc. Non-Invasive Drug Delivery Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 32. Novartis AG Major Business
Table 33. Novartis AG Non-Invasive Drug Delivery Product and Services
Table 34. Novartis AG Non-Invasive Drug Delivery Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. PenJet Corporation Basic Information, Manufacturing Base and Competitors
Table 36. PenJet Corporation Major Business
Table 37. PenJet Corporation Non-Invasive Drug Delivery Product and Services
Table 38. PenJet Corporation Non-Invasive Drug Delivery Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. PharmaJet Basic Information, Manufacturing Base and Competitors
Table 40. PharmaJet Major Business
Table 41. PharmaJet Non-Invasive Drug Delivery Product and Services
Table 42. PharmaJet Non-Invasive Drug Delivery Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Portal Instruments Basic Information, Manufacturing Base and Competitors
Table 44. Portal Instruments Major Business
Table 45. Portal Instruments Non-Invasive Drug Delivery Product and Services
Table 46. Portal Instruments Non-Invasive Drug Delivery Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. ResMed Basic Information, Manufacturing Base and Competitors
Table 48. ResMed Major Business
Table 49. ResMed Non-Invasive Drug Delivery Product and Services
Table 50. ResMed Non-Invasive Drug Delivery Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Sensiron AG Basic Information, Manufacturing Base and Competitors
Table 52. Sensiron AG Major Business
Table 53. Sensiron AG Non-Invasive Drug Delivery Product and Services
Table 54. Sensiron AG Non-Invasive Drug Delivery Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Tandem Diabetes Care, Inc. Basic Information, Manufacturing Base and Competitors
Table 56. Tandem Diabetes Care, Inc. Major Business
Table 57. Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Product and Services
Table 58. Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Teva Pharmaceuticals Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 60. Teva Pharmaceuticals Industries Ltd. Major Business
Table 61. Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Product and Services
Table 62. Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Global Non-Invasive Drug Delivery Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 64. Global Non-Invasive Drug Delivery Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 65. Market Position of Manufacturers in Non-Invasive Drug Delivery, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 66. Global Non-Invasive Drug Delivery Production Capacity by Company, (K Units): 2020 VS 2021
Table 67. Head Office and Non-Invasive Drug Delivery Production Site of Key Manufacturer
Table 68. Non-Invasive Drug Delivery New Entrant and Capacity Expansion Plans
Table 69. Non-Invasive Drug Delivery Mergers & Acquisitions in the Past Five Years
Table 70. Global Non-Invasive Drug Delivery Sales by Region (2017-2022) & (K Units)
Table 71. Global Non-Invasive Drug Delivery Sales by Region (2023-2028) & (K Units)
Table 72. Global Non-Invasive Drug Delivery Revenue by Region (2017-2022) & (USD Million)
Table 73. Global Non-Invasive Drug Delivery Revenue by Region (2023-2028) & (USD Million)
Table 74. Global Non-Invasive Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 75. Global Non-Invasive Drug Delivery Sales by Type (2023-2028) & (K Units)
Table 76. Global Non-Invasive Drug Delivery Revenue by Type (2017-2022) & (USD Million)
Table 77. Global Non-Invasive Drug Delivery Revenue by Type (2023-2028) & (USD Million)
Table 78. Global Non-Invasive Drug Delivery Price by Type (2017-2022) & (US$/Unit)
Table 79. Global Non-Invasive Drug Delivery Price by Type (2023-2028) & (US$/Unit)
Table 80. Global Non-Invasive Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 81. Global Non-Invasive Drug Delivery Sales by Application (2023-2028) & (K Units)
Table 82. Global Non-Invasive Drug Delivery Revenue by Application (2017-2022) & (USD Million)
Table 83. Global Non-Invasive Drug Delivery Revenue by Application (2023-2028) & (USD Million)
Table 84. Global Non-Invasive Drug Delivery Price by Application (2017-2022) & (US$/Unit)
Table 85. Global Non-Invasive Drug Delivery Price by Application (2023-2028) & (US$/Unit)
Table 86. North America Non-Invasive Drug Delivery Sales by Country (2017-2022) & (K Units)
Table 87. North America Non-Invasive Drug Delivery Sales by Country (2023-2028) & (K Units)
Table 88. North America Non-Invasive Drug Delivery Revenue by Country (2017-2022) & (USD Million)
Table 89. North America Non-Invasive Drug Delivery Revenue by Country (2023-2028) & (USD Million)
Table 90. North America Non-Invasive Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 91. North America Non-Invasive Drug Delivery Sales by Type (2023-2028) & (K Units)
Table 92. North America Non-Invasive Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 93. North America Non-Invasive Drug Delivery Sales by Application (2023-2028) & (K Units)
Table 94. Europe Non-Invasive Drug Delivery Sales by Country (2017-2022) & (K Units)
Table 95. Europe Non-Invasive Drug Delivery Sales by Country (2023-2028) & (K Units)
Table 96. Europe Non-Invasive Drug Delivery Revenue by Country (2017-2022) & (USD Million)
Table 97. Europe Non-Invasive Drug Delivery Revenue by Country (2023-2028) & (USD Million)
Table 98. Europe Non-Invasive Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 99. Europe Non-Invasive Drug Delivery Sales by Type (2023-2028) & (K Units)
Table 100. Europe Non-Invasive Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 101. Europe Non-Invasive Drug Delivery Sales by Application (2023-2028) & (K Units)
Table 102. Asia-Pacific Non-Invasive Drug Delivery Sales by Region (2017-2022) & (K Units)
Table 103. Asia-Pacific Non-Invasive Drug Delivery Sales by Region (2023-2028) & (K Units)
Table 104. Asia-Pacific Non-Invasive Drug Delivery Revenue by Region (2017-2022) & (USD Million)
Table 105. Asia-Pacific Non-Invasive Drug Delivery Revenue by Region (2023-2028) & (USD Million)
Table 106. Asia-Pacific Non-Invasive Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 107. Asia-Pacific Non-Invasive Drug Delivery Sales by Type (2023-2028) & (K Units)
Table 108. Asia-Pacific Non-Invasive Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 109. Asia-Pacific Non-Invasive Drug Delivery Sales by Application (2023-2028) & (K Units)
Table 110. South America Non-Invasive Drug Delivery Sales by Country (2017-2022) & (K Units)
Table 111. South America Non-Invasive Drug Delivery Sales by Country (2023-2028) & (K Units)
Table 112. South America Non-Invasive Drug Delivery Revenue by Country (2017-2022) & (USD Million)
Table 113. South America Non-Invasive Drug Delivery Revenue by Country (2023-2028) & (USD Million)
Table 114. South America Non-Invasive Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 115. South America Non-Invasive Drug Delivery Sales by Type (2023-2028) & (K Units)
Table 116. South America Non-Invasive Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 117. South America Non-Invasive Drug Delivery Sales by Application (2023-2028) & (K Units)
Table 118. Middle East & Africa Non-Invasive Drug Delivery Sales by Region (2017-2022) & (K Units)
Table 119. Middle East & Africa Non-Invasive Drug Delivery Sales by Region (2023-2028) & (K Units)
Table 120. Middle East & Africa Non-Invasive Drug Delivery Revenue by Region (2017-2022) & (USD Million)
Table 121. Middle East & Africa Non-Invasive Drug Delivery Revenue by Region (2023-2028) & (USD Million)
Table 122. Middle East & Africa Non-Invasive Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 123. Middle East & Africa Non-Invasive Drug Delivery Sales by Type (2023-2028) & (K Units)
Table 124. Middle East & Africa Non-Invasive Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 125. Middle East & Africa Non-Invasive Drug Delivery Sales by Application (2023-2028) & (K Units)
Table 126. Non-Invasive Drug Delivery Raw Material
Table 127. Key Manufacturers of Non-Invasive Drug Delivery Raw Materials
Table 128. Direct Channel Pros & Cons
Table 129. Indirect Channel Pros & Cons
Table 130. Non-Invasive Drug Delivery Typical Distributors
Table 131. Non-Invasive Drug Delivery Typical Customers
List of Figures
Figure 1. Non-Invasive Drug Delivery Picture
Figure 2. Global Non-Invasive Drug Delivery Revenue Market Share by Type in 2021
Figure 3. Artificial Pancreas
Figure 4. Needle Free Injector
Figure 5. Digital Respiratory Devices
Figure 6. Other
Figure 7. Global Non-Invasive Drug Delivery Revenue Market Share by Application in 2021
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global Non-Invasive Drug Delivery Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Non-Invasive Drug Delivery Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Non-Invasive Drug Delivery Sales (2017-2028) & (K Units)
Figure 14. Global Non-Invasive Drug Delivery Price (2017-2028) & (US$/Unit)
Figure 15. Global Non-Invasive Drug Delivery Production Capacity (2017-2028) & (K Units)
Figure 16. Global Non-Invasive Drug Delivery Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Non-Invasive Drug Delivery Market Drivers
Figure 18. Non-Invasive Drug Delivery Market Restraints
Figure 19. Non-Invasive Drug Delivery Market Trends
Figure 20. Global Non-Invasive Drug Delivery Sales Market Share by Manufacturer in 2021
Figure 21. Global Non-Invasive Drug Delivery Revenue Market Share by Manufacturer in 2021
Figure 22. Non-Invasive Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Non-Invasive Drug Delivery Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Non-Invasive Drug Delivery Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Non-Invasive Drug Delivery Sales Market Share by Region (2017-2028)
Figure 26. Global Non-Invasive Drug Delivery Revenue Market Share by Region (2017-2028)
Figure 27. North America Non-Invasive Drug Delivery Revenue (2017-2028) & (USD Million)
Figure 28. Europe Non-Invasive Drug Delivery Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Non-Invasive Drug Delivery Revenue (2017-2028) & (USD Million)
Figure 30. South America Non-Invasive Drug Delivery Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Non-Invasive Drug Delivery Revenue (2017-2028) & (USD Million)
Figure 32. Global Non-Invasive Drug Delivery Sales Market Share by Type (2017-2028)
Figure 33. Global Non-Invasive Drug Delivery Revenue Market Share by Type (2017-2028)
Figure 34. Global Non-Invasive Drug Delivery Price by Type (2017-2028) & (US$/Unit)
Figure 35. Global Non-Invasive Drug Delivery Sales Market Share by Application (2017-2028)
Figure 36. Global Non-Invasive Drug Delivery Revenue Market Share by Application (2017-2028)
Figure 37. Global Non-Invasive Drug Delivery Price by Application (2017-2028) & (US$/Unit)
Figure 38. North America Non-Invasive Drug Delivery Sales Market Share by Type (2017-2028)
Figure 39. North America Non-Invasive Drug Delivery Sales Market Share by Application (2017-2028)
Figure 40. North America Non-Invasive Drug Delivery Sales Market Share by Country (2017-2028)
Figure 41. North America Non-Invasive Drug Delivery Revenue Market Share by Country (2017-2028)
Figure 42. United States Non-Invasive Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Non-Invasive Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Non-Invasive Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Non-Invasive Drug Delivery Sales Market Share by Type (2017-2028)
Figure 46. Europe Non-Invasive Drug Delivery Sales Market Share by Application (2017-2028)
Figure 47. Europe Non-Invasive Drug Delivery Sales Market Share by Country (2017-2028)
Figure 48. Europe Non-Invasive Drug Delivery Revenue Market Share by Country (2017-2028)
Figure 49. Germany Non-Invasive Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Non-Invasive Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Non-Invasive Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Non-Invasive Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Non-Invasive Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Non-Invasive Drug Delivery Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Non-Invasive Drug Delivery Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Non-Invasive Drug Delivery Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Non-Invasive Drug Delivery Revenue Market Share by Region (2017-2028)
Figure 58. China Non-Invasive Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Non-Invasive Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Non-Invasive Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Non-Invasive Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Non-Invasive Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Non-Invasive Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Non-Invasive Drug Delivery Sales Market Share by Type (2017-2028)
Figure 65. South America Non-Invasive Drug Delivery Sales Market Share by Application (2017-2028)
Figure 66. South America Non-Invasive Drug Delivery Sales Market Share by Country (2017-2028)
Figure 67. South America Non-Invasive Drug Delivery Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Non-Invasive Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Non-Invasive Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Non-Invasive Drug Delivery Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Non-Invasive Drug Delivery Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Non-Invasive Drug Delivery Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Non-Invasive Drug Delivery Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Non-Invasive Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Non-Invasive Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Non-Invasive Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Non-Invasive Drug Delivery Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Non-Invasive Drug Delivery in 2021
Figure 79. Manufacturing Process Analysis of Non-Invasive Drug Delivery
Figure 80. Non-Invasive Drug Delivery Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
